PlusNews/IRIN examines HIV/AIDS elements of new adult mortality data

NewsGuard 100/100 Score

PlusNews/IRIN examines what the global adult mortality data, released Friday in the journal Lancet, suggests about HIV/AIDS. According to the news service, the study, based on an analysis of adult mortality rates between 1970 and 2010 in 187 countries, revealed: "HIV was key to reversing the worldwide decline in mortality from 1970 to 1990. Even though worldwide mortality is still about 26 percent lower than it was 40 years ago, there are regional imbalances. In sub-Saharan Africa, hard hit by HIV, mortality is at levels not seen in developed countries such as Sweden since the 1700s."

Though the data reflected the impact of HIV/AIDS on populations, study co-author Christopher Murray of the Institute for Health Metrics and Evaluation, said the study also captured "[a]n emerging public health success story ... the scale-up of antiretroviral [ARV] therapies in Africa, [which] seems to be one of the drivers in the declines in mortality that we have seen in many countries there since 2005."

Murray also emphasized the need for countries to improve their ability to accurately track disease outcomes among their adult populations (4/30).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers receive NIH grant to help develop gene therapy for HIV